Return of Meme Mania?, Disney Drama 3/27/24

Return of Meme Mania?, Disney Drama 3/27/24

Up next

SK Hynix Pops in Nasdaq Debut, Recapping the Russell Rally, Energy Market on Edge 7/10/26

The S&P 500 is on track for a weekly gain as mega-cap tech stocks lead the index higher on Friday. Brian Sullivan and Kelly Evans are joined on set by Hightower Advisors’ Stephanie Link and Advisors Capital Management’s Joanne Feeney to react to SK Hynix’s U.S. market debut on th ...  Show more

Big Tech Bounces Back, Baker Hughes CEO, & Powering the AI Revolution 7/9/26

Stocks rose on Thursday, supported by a jump in semiconductors and a fall in oil prices, as equity markets tried to recover despite renewed U.S.-Iran tensions. Kelly Evans and Brian Sullivan are joined on-set by Carson Group’s Ryan Detrick who provides his mid-year market report ...  Show more

Recommended Episodes

Delta, Disney, and your Dollars
Halftime Report

Scott Wapner and the Investment Committee debate Disney’s big earnings beat and what it means for the stocks. Plus, what do the numbers say about the reopening trade. And later, we take a look at next week’s flood of retail earnings reports, what should you buy ahead of the news. ...  Show more

Golden Arches comeback
Wall Street Breakfast

The Minecraft Movie Meal helped sales at McDonald’s rebound. (0:10) Super Micro shares tumble. (2:21) Telsa, Musk sued over robotaxi. (2:46)Show NotesThe competition for ‘dip alpha’ is heating up Episode transcripts seekingalpha.com/wsb. Sign up for our daily newsletter here and ...  Show more

Market Rebounds and Disney Reopenings
Motley Fool Hidden Gems Investing

The total number of unemployment claims climbs above 40 million. Costco slips on earnings. Salesforce sells off. Dollar Tree and Dollar General rise on strong growth. Williams-Sonoma serves up a surprise. And Hertz Global files for Chapter 11. Motley Fool analysts Ron Gross and J ...  Show more

Big Pharma Breakout… And A Billionaire Boycott On Netflix 10/1/25
CNBC's "Fast Money"

Pharma stocks breaking out, as President Trump inks a drug pricing deal. What it means for the group, and how the broader health care sector is breathing a sigh of relief. Plus Elon Musk and some bingeing backlash. Why the billionaire is calling for customers to cancel their s ...

  Show more